Ethic Inc. Decreases Holdings in The Clorox Company $CLX

Ethic Inc. trimmed its position in shares of The Clorox Company (NYSE:CLX) by 21.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,178 shares of the company’s stock after selling 4,049 shares during the period. Ethic Inc.’s holdings in Clorox were worth $1,808,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Simplicity Wealth LLC raised its holdings in shares of Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after buying an additional 11,198 shares in the last quarter. Raymond James Financial Inc. grew its position in Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after acquiring an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC bought a new position in Clorox during the 1st quarter worth approximately $247,000. Bank of New York Mellon Corp grew its position in Clorox by 1.3% during the 1st quarter. Bank of New York Mellon Corp now owns 826,158 shares of the company’s stock worth $121,652,000 after acquiring an additional 10,255 shares during the last quarter. Finally, Liberty One Investment Management LLC grew its position in Clorox by 2.9% during the 1st quarter. Liberty One Investment Management LLC now owns 201,741 shares of the company’s stock worth $29,706,000 after acquiring an additional 5,702 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on CLX. The Goldman Sachs Group reduced their price target on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. BNP Paribas Exane reduced their price target on Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a research report on Friday, October 17th. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research report on Monday, October 13th. Barclays cut their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. Finally, Wells Fargo & Company cut their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 25th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $130.20.

Clorox Price Performance

Shares of CLX stock opened at $116.02 on Friday. The firm has a market cap of $14.13 billion, a P/E ratio of 17.79, a P/E/G ratio of 0.96 and a beta of 0.52. The Clorox Company has a fifty-two week low of $115.83 and a fifty-two week high of $171.37. The business’s 50 day moving average price is $121.18 and its 200-day moving average price is $126.94. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.63% of the stock is currently owned by insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.